EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Therapeutic Potential of Graphene Quantum Dots on Pterygium Cells

Donghoon Koo, Minji Kim, Hyun Seung Yang, Jeongmin Kim

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.14.9 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Donghoon Koo and 3 co-authors. Institution: Department of Applied Bioengineering, Seoul National University, Seoul, Republic of Korea. Major MEDLINE topics: Pterygium, Fibroblasts, Quantum Dots, Graphite. Cited 1 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

To evaluate the therapeutic potential of graphene quantum dots (GQDs) in modulating key pathological processes in pterygium, including abnormal cell proliferation, migration, and extracellular matrix remodeling.

Methods

Primary fibroblast cells from human pterygium and conjunctival tissues were cultured and treated with GQDs (6.25-100 µg/mL). Cell cytotoxicity and viability were assessed using live/dead and CCK-8 assays. Cell migration was evaluated via scratch wound-healing assays. Microtubule integrity was analyzed using α-tubulin immunocytochemistry and super-resolution stochastic optical reconstruction microscopy imaging. Expression of pathological proteins (cyclin D1, CDK2, periostin, matrix metalloproteinase [MMP]-3, and MMP-9) was quantified by Western blotting.

Results

GQDs selectively impaired pathological behaviors in pterygium fibroblasts, reducing viability and migration in a dose-dependent manner, with minimal effects on conjunctival fibroblasts. Stochastic optical reconstruction microscopy imaging revealed GQD-induced microtubule fragmentation in pterygium fibroblasts. GQDs also significantly downregulated cyclin D1, CDK2, periostin, MMP-3, and MMP-9.

Conclusions

GQDs suppress multiple pathologic features of pterygium, including selective cytotoxicity, downregulation of key molecular mediators (cyclin D1, periostin, MMP-3, and MMP-9), and a novel mechanism involving microtubule fragmentation. These findings support the potential of GQDs as a noninvasive therapeutic strategy to suppress pterygium progression and decrease postoperative recurrence.

Subjects

MeSH terms (MEDLINE)

PterygiumFibroblastsQuantum DotsGraphiteHumansCell MovementCells, CulturedCell ProliferationBlotting, WesternCell SurvivalConjunctivaMatrix Metalloproteinase 9Cell Adhesion MoleculesMatrix Metalloproteinase 3ImmunohistochemistryCyclin D1

Substances

GraphiteMatrix Metalloproteinase 9Cell Adhesion MoleculesPOSTN protein, humanMatrix Metalloproteinase 3Cyclin D1

Authors and institutions

  • Department of Applied Bioengineering, Seoul National University, Seoul, Republic of Korea.
  • Department of Ophthalmology, Seoul Shinsegae Eye Center, Eui Jung Bu, Gyeonggi-do, Republic of Korea.
  • Laboratory of Cell Image, Seoul Shinsegae Eye Center, Seoul, Republic of Korea.
  • Research Institute for Convergence Science, Seoul National University, Seoul, Republic of Korea.
  • Advanced Institute of Convergence Technology, Suwon, Republic of Korea.

Cite

APA

Koo, D., Kim, M., Yang, H. S., & Kim, J. (2025). Therapeutic Potential of Graphene Quantum Dots on Pterygium Cells. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.14.9

Vancouver

Koo D, Kim M, Yang HS, Kim J. Therapeutic Potential of Graphene Quantum Dots on Pterygium Cells. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.14.9

BibTeX
@article{Koo2025,
  author = {Koo, Donghoon and Kim, Minji and Yang, Hyun Seung and Kim, Jeongmin},
  title = {Therapeutic Potential of Graphene Quantum Dots on Pterygium Cells},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.14.9}
}
Start for free →